Case Study: Feasibility Analysis of a Cost-benefit Assessment for a Gene Therapy
Client Challenge The gene therapy of the pharmaceutical company had a very high price compared to other therapy options in […]
Case Study: Strategic Guide to a Global Market Access Strategy for Multiple Indications
Client Challenge Our client tasked us with developing a global strategic guidance to facilitate national market access for their asset
Case Study: Re-negotiating a DHSC Price Decision on a Women’s Health Product
Client Challenge Our client was ready to launch their women’s health product and sought Kintiga’s support to develop a price
Case Study: Upskilling International Market Access Teams
Client Challenge A large pharma company was looking for Market Access training for their multi-disciplinary team in the UK, with
Case Study: Staying Ahead in an Evolving Reimbursement and Market Access Policy Landscape
Client Challenge Our client, a pharmaceutical company with a diverse pipeline of assets, aims to stay informed of developments in
Case Study: Re-entry After a Market Exit – Requirements, Chances and Risks
Client Challenge The pharmaceutical company’s therapy met the special requirements of the AMNOG procedure in Germany, but had to be
Market Access Agenda in Europe – A Video Interview on EU HTA
Author: Dr. Matthias Schönermark Insightful discussion with Prof. Dr. Matthias P. Schönermark, and Oznur Seyhun, Partner & Anchorwoman at Market
